Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.

Barth H, Rybczynska J, Patient R, Choi Y, Sapp RK, Baumert TF, Krawczynski K, Liang TJ.

Hepatology. 2011 Oct;54(4):1135-48. doi: 10.1002/hep.24489. Epub 2011 Aug 11.

2.

Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.

Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, Feinstone SM, Rehermann B.

J Virol. 2003 Apr;77(8):4781-93.

3.

Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.

Bukh J, Thimme R, Meunier JC, Faulk K, Spangenberg HC, Chang KM, Satterfield W, Chisari FV, Purcell RH.

J Virol. 2008 Aug;82(16):8183-95. doi: 10.1128/JVI.00142-08. Epub 2008 Jun 11.

4.

Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.

Major ME, Mihalik K, Puig M, Rehermann B, Nascimbeni M, Rice CM, Feinstone SM.

J Virol. 2002 Jul;76(13):6586-95.

5.

Lack of protective immunity against reinfection with hepatitis C virus.

Farci P, Alter HJ, Govindarajan S, Wong DC, Engle R, Lesniewski RR, Mushahwar IK, Desai SM, Miller RH, Ogata N, et al.

Science. 1992 Oct 2;258(5079):135-40.

PMID:
1279801
6.

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees.

Elmowalid GA, Qiao M, Jeong SH, Borg BB, Baumert TF, Sapp RK, Hu Z, Murthy K, Liang TJ.

Proc Natl Acad Sci U S A. 2007 May 15;104(20):8427-32. Epub 2007 May 7.

7.

Innate and adaptive immune responses in HCV infections.

Heim MH, Thimme R.

J Hepatol. 2014 Nov;61(1 Suppl):S14-25. doi: 10.1016/j.jhep.2014.06.035. Epub 2014 Nov 3. Review.

8.

Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins.

Dahari H, Feinstone SM, Major ME.

Gastroenterology. 2010 Sep;139(3):965-74. doi: 10.1053/j.gastro.2010.05.077. Epub 2010 Jun 2.

9.

Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.

Bassett SE, Guerra B, Brasky K, Miskovsky E, Houghton M, Klimpel GR, Lanford RE.

Hepatology. 2001 Jun;33(6):1479-87.

PMID:
11391537
10.

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

Forns X, Payette PJ, Ma X, Satterfield W, Eder G, Mushahwar IK, Govindarajan S, Davis HL, Emerson SU, Purcell RH, Bukh J.

Hepatology. 2000 Sep;32(3):618-25.

PMID:
10960458
11.

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

Folgori A, Capone S, Ruggeri L, Meola A, Sporeno E, Ercole BB, Pezzanera M, Tafi R, Arcuri M, Fattori E, Lahm A, Luzzago A, Vitelli A, Colloca S, Cortese R, Nicosia A.

Nat Med. 2006 Feb;12(2):190-7. Epub 2006 Feb 5.

PMID:
16462801
12.

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.

Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, Ray SC, Thomas DL, Cox AL.

Gastroenterology. 2010 Jan;138(1):315-24. doi: 10.1053/j.gastro.2009.09.017. Epub 2009 Sep 24.

13.

Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee.

Youn JW, Park SH, Lavillette D, Cosset FL, Yang SH, Lee CG, Jin HT, Kim CM, Shata MT, Lee DH, Pfahler W, Prince AM, Sung YC.

Hepatology. 2005 Dec;42(6):1429-36.

PMID:
16317673
14.

Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus.

Youn JW, Hu YW, Tricoche N, Pfahler W, Shata MT, Dreux M, Cosset FL, Folgori A, Lee DH, Brotman B, Prince AM.

J Virol. 2008 Nov;82(21):10896-905. doi: 10.1128/JVI.01179-08. Epub 2008 Aug 27.

15.
16.

Complete definition of immunological correlates of protection and clearance of hepatitis C virus infection: a relevant pending task for vaccine development.

Alvarez-Lajonchere L, DueƱas-Carrera S.

Int Rev Immunol. 2012 Jun;31(3):223-42. doi: 10.3109/08830185.2012.680552. Review.

PMID:
22587022
17.

Immune and non-immune responses to hepatitis C virus infection.

Sun J, Rajsbaum R, Yi M.

World J Gastroenterol. 2015 Oct 14;21(38):10739-48. doi: 10.3748/wjg.v21.i38.10739. Review.

18.

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

Swadling L, Capone S, Antrobus RD, Brown A, Richardson R, Newell EW, Halliday J, Kelly C, Bowen D, Fergusson J, Kurioka A, Ammendola V, Del Sorbo M, Grazioli F, Esposito ML, Siani L, Traboni C, Hill A, Colloca S, Davis M, Nicosia A, Cortese R, Folgori A, Klenerman P, Barnes E.

Sci Transl Med. 2014 Nov 5;6(261):261ra153. doi: 10.1126/scitranslmed.3009185.

19.

Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.

Shata MT, Tricoche N, Perkus M, Tom D, Brotman B, McCormack P, Pfahler W, Lee DH, Tobler LH, Busch M, Prince AM.

Virology. 2003 Sep 30;314(2):601-16.

20.

Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.

Cao J, Chen Z, Ren Y, Luo Y, Cao M, Lu W, Zhao P, Qi Z.

Vaccine. 2011 May 9;29(20):3714-23. doi: 10.1016/j.vaccine.2011.02.083. Epub 2011 Mar 9.

PMID:
21396407

Supplemental Content

Support Center